Established in 1989, Shanghai Fosun Long March Medical Science Co., Ltd (herein after as Fosun Long March) is a high tech in-vitro diagnostics enterprise who is active in manufacturing, marketing and research and development of diagnostic and laboratory instrument and reagent. At the moment, Shanghai Fosun Long March Medical Science Co., Ltd is a wholly owned company by Shanghai Fosunpharma (Group), a China Fortune 500 company.
With product range from Clinical Chemistry kits, ELISA kits, Immunoturbidimetry kits , blood gas to electrolyte analyzer kits, we become one of the most influential brands in in-vitro diagnostics area. Our national wide sales network provides our customers products with good reputation. Being quick and efficient, our after-sales service network meets the demand of our customers whom spread throughout the country. Our products are manufactured under GMP and ISO13485 certification.
We have approximately 300 employees in the company. Fosun Long March has been rewarded with prizes by Ministry of Health, Shanghai Science and Technical Committee and Industry Associations. Also Fosun Long March has been recognized as "High-Tech Enterprise" by Shanghai Government.
As the investment platform of IVD division of FosunPharma Group, Fosun Long March has speeded up merger and acquisition in the centre of new product introduction. We directly hold Yaneng Biosciences (Shenzhen) Co., Ltd, Shanghai Fosun Med-Tech Development Co., Shanghai Biofosun Biotech Co., Ltd and Jiangsu Star Diagnostics Co.,Ltd. We partly hold SINNOWA Medical Science & Technology Co., LTD and Steellex Scientific Instrument Company. At the same time, we also have close cooperation with Saladax USA, Oxford Immunotec UK, and SDB Korea through FosunPharma.
Currently the company has obtained CFDA approval for a hundred products, and more than ten patents. The imported product T-spot TB, as only authorized tuberculosis diagnosis kits in China market, filled the gaps in this field for domestic market.
Fosun Long March strives to be the leading provider of in-vitro diagnostics solutions in China. We will continue our research and development, introduction of advanced technology and cooperation with research institute in future.